United-Guardian Inc. (UG)
NASDAQ: UG
· Real-Time Price · USD
8.30
-0.01 (-0.12%)
At close: May 30, 2025, 3:59 PM
8.30
0.00%
After-hours: May 30, 2025, 04:04 PM EDT
United-Guardian Revenue Breakdown
| Period Ending | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|
| Industrial And Other Revenue | 159.94K | 174.36K | 169.49K | 164.01K | 153.5K |
| Industrial And Other Revenue Growth | -8.27% | +2.88% | +3.34% | +6.85% | n/a |
| Medical Revenue | 2.62M | 2.2M | 2.49M | 3.03M | 2.9M |
| Medical Revenue Growth | +19.09% | -11.64% | -17.65% | +4.28% | n/a |
| Personal Care Revenue | 4.92M | 9.92M | 9.42M | 11.46M | 9.44M |
| Personal Care Revenue Growth | -50.45% | +5.32% | -17.79% | +21.41% | n/a |
| Pharmaceuticals Revenue | 3.44M | 1.86M | 1.69M | 916.93K | 1.52M |
| Pharmaceuticals Revenue Growth | +84.71% | +10.53% | +83.94% | -39.86% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 594.13K | n/a | 602.78K | 568.87K | 498.06K | 488.46K | 574.09K | 517.95K | n/a | 532.33K | 620.23K | 546.75K | 607.25K | 458.58K | 513.01K | 457.13K | 506.25K | 493.2K | 511.63K | 515.27K | 555.14K | 544.18K | 502.09K | 546.96K | -1.58M | 519.33K | 534.42K | 524.11K | 464.82K | 438.26K | 418.61K | 463.48K | 459.55K | 460.4K | 465.33K | 467.56K | 545.75K | 372.62K | 600.53K | 627.24K |
| Selling, General, and Administrative Revenue Growth | -100.00% | n/a | -100.00% | +5.96% | +14.22% | +1.96% | -14.92% | +10.84% | n/a | -100.00% | -14.17% | +13.44% | -9.96% | +32.42% | -10.61% | +12.23% | -9.70% | +2.65% | -3.60% | -0.71% | -7.18% | +2.02% | +8.38% | -8.20% | -134.66% | -403.83% | -2.82% | +1.97% | +12.76% | +6.06% | +4.69% | -9.68% | +0.86% | -0.19% | -1.06% | -0.48% | -14.33% | +46.46% | -37.95% | -4.26% | n/a |
| Research and Development Revenue | 114.39K | 131.06K | 111.07K | 111.66K | 102.98K | 110.16K | 98.14K | 128.73K | 126.96K | 125.91K | 120.92K | 112.27K | 131.67K | 129.59K | 130.74K | 130.03K | 88.29K | 120.07K | 114.84K | 108.57K | 107.73K | 100.09K | 104.8K | 93.85K | 98.66K | 108.27K | 98.3K | 91.28K | 101.66K | 138.54K | 159.53K | 158.28K | 189.73K | 157.77K | 158.59K | 157.9K | 177.57K | 141.26K | 223.1K | 156.54K | 166.31K |
| Research and Development Revenue Growth | -12.72% | +18.00% | -0.53% | +8.43% | -6.52% | +12.25% | -23.76% | +1.39% | +0.83% | +4.13% | +7.71% | -14.73% | +1.60% | -0.88% | +0.55% | +47.28% | -26.47% | +4.56% | +5.78% | +0.77% | +7.64% | -4.50% | +11.67% | -4.88% | -8.87% | +10.14% | +7.69% | -10.21% | -26.62% | -13.16% | +0.79% | -16.58% | +20.25% | -0.52% | +0.44% | -11.08% | +25.70% | -36.68% | +42.52% | -5.87% | n/a |